Efficacy of Metadoxine Extended Release in Patients With Predominantly Inattentive Subtype Attention-Deficit/Hyperactivity Disorder

Postgraduate Medicine ◽

10.3810/pgm.2013.07.2689 ◽

2013 ◽

Vol 125 (4) ◽

pp. 181-190 ◽

Author(s):

Iris Manor ◽

Jeffrey H. Newcorn ◽

Stephen V. Faraone ◽

Lenard A. Adler ◽

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Hyperactivity Disorder ◽

Inattentive Subtype

Download Full-text

Effectiveness of an extended release stimulant medication in treating preschool children with attention deficit hyperactivity disorder (The APS Study)

PsycEXTRA Dataset ◽

10.1037/e657832010-001 ◽

2010 ◽

Author(s):

John H. Fanton

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Preschool Children ◽

Attention Deficit ◽

Extended Release ◽

Stimulant Medication ◽

Hyperactivity Disorder

Download Full-text

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior stimulant treatment

10.26226/morressier.5785edd1d462b80296c9a2a5 ◽

2016 ◽

Author(s):

Jiri Prochazka

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Stimulant Treatment ◽

Hyperactivity Disorder

Download Full-text

Evaluating the Likelihood to be Helped or Harmed after Treatment with Viloxazine Extended‐Release in Children and Adolescents with Attention Deficit/Hyperactivity Disorder

International Journal of Clinical Practice ◽

10.1111/ijcp.14330 ◽

2021 ◽

Author(s):

Azmi Nasser ◽

Alisa R. Kosheleff ◽

Joseph T. Hull ◽

Tesfaye Liranso ◽

Peibing Qin ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Hyperactivity Disorder

Download Full-text

A Cost-Effectiveness Analysis of Guanfacine Extended-Release Treatment in Pediatric Attention-Deficit/Hyperactivity Disorder

Value in Health ◽

10.1016/j.jval.2016.08.529 ◽

2016 ◽

Vol 19 (7) ◽

pp. A841

Author(s):

S Maeda ◽

K Shimozuma ◽

Y Takeda

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Cost Effectiveness ◽

Attention Deficit ◽

Extended Release ◽

Cost Effectiveness Analysis ◽

Hyperactivity Disorder ◽

Effectiveness Analysis

Download Full-text

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

European Archives of Psychiatry and Clinical Neuroscience ◽

10.1007/s00406-009-0005-5 ◽

2009 ◽

Vol 259 (6) ◽

pp. 368-368 ◽

Author(s):

Michael Rösler ◽

◽

Roland Fischer ◽

Richard Ammer ◽

Claudia Ose ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Low Dose ◽

Hyperactivity Disorder

Download Full-text

PIH23 Cost-Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Psychostimulant Compared to Psychostimulant Monotherapy for the Treatment of Attention Deficit/Hyperactivity Disorder in Children and Adolescents

Value in Health ◽

10.1016/j.jval.2011.08.927 ◽

2011 ◽

Vol 14 (7) ◽

pp. A401-A402 ◽

Author(s):

V. Sikirica ◽

M. Erder ◽

J. Xie ◽

D. Macaulay ◽

M. Diener ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Cost Effectiveness ◽

Children And Adolescents ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Extended Release ◽

Hyperactivity Disorder

Download Full-text

4.23 PIVOTAL PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF HLD200, A NOVEL DELAYED-RELEASE AND EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE, IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.218 ◽

2016 ◽

Vol 55 (10) ◽

pp. S170

Author(s):

Valerie K. Arnold ◽

Norberto J. DeSousa ◽

Bev Incledon ◽

Floyd R. Sallee ◽

Timothy E. Wilens ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Phase 3 ◽

Pivotal Phase ◽

Release Formulation ◽

Extended Release Formulation ◽

Hyperactivity Disorder ◽

Delayed Release

Download Full-text

Amphetamine extended-release oral suspension for attention-deficit/hyperactivity disorder

Expert Review of Clinical Pharmacology ◽

10.1080/17512433.2019.1659723 ◽

2019 ◽

Vol 12 (10) ◽

pp. 965-971

Author(s):

Ann C. Childress ◽

Heather Chow

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Oral Suspension ◽

Hyperactivity Disorder

Download Full-text

Correction to: Amphetamine extended-release oral suspension (Adzenys ER™) and orally disintegrating tablets (Adzenys XR-ODT®) in attention-deficit hyperactivity disorder: a profile of their use

Drugs & Therapy Perspectives ◽

10.1007/s40267-018-0567-2 ◽

2018 ◽

Vol 34 (12) ◽

pp. 596-596

Author(s):

Katherine A. Lyseng-Williamson

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Oral Suspension ◽

Hyperactivity Disorder ◽

Orally Disintegrating Tablets

Download Full-text

A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.05.021 ◽

2020 ◽

Vol 42 (8) ◽

pp. 1452-1466 ◽

Author(s):

Azmi Nasser ◽

Tesfaye Liranso ◽

Toyin Adewole ◽

Nicholas Fry ◽

Joseph T. Hull ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Controlled Trial ◽

Phase Iii ◽

School Age Children ◽

Efficacy And Safety ◽

Hyperactivity Disorder

Download Full-text